Moderna: 30,000 Participants Enrolled in COVID-19 Vaccine Trial
The trial is investigating the efficacy, safety, and immunogenicity of mRNA-1273 at the 100mcg dose.
Vaccine Information Center
Novel Pneumococcal Conjugate Vaccine Immunogenic in Phase 3 Trials
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
Survey Reveals Factors Contributing to COVID-19 Vaccine Acceptance
To estimate the association between attribute level and probability of choosing and receiving a vaccine, the study authors calculated the average marginal component effects sizes as well as marginal means.
Only Two-Thirds of Parents Planning to Get Flu Shots for Their Children
One-third of parents say they will forgo the flu vaccination for their children this year, despite public health recommendations.
ACIP Provides Recommendations on Meningococcal Vaccination
Routine vaccination with a quadrivalent meningococcal conjugate vaccine is recommended for adolescents aged 11 to 12 years.
COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study
The Medicines Health Regulatory Authority confirmed that the AZD1222 trial could proceed after a UK committee concluded its investigations.
Single-Dose Nirsevimab Provides Season-Long RSV Protection for Preterm Infants
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
Safety, Immunogenicity of Investigational Inactivated Whole-Virus COVID-19 Vaccine
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.
Underutilization of Influenza Vaccination in Populations at High-Risk for Complications
Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.
ACIP: Influenza Vaccination Recommendations for 2020-2021
Influenza vaccination should occur by the end of October, if possible.
HHS Authorizes Pharmacists to Administer Vaccines to Children
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Postmarketing Surveillance Demonstrates Remarkable Safety of Vaccines
Vaccines are a key public health strategy that is remarkably safe due to continued postmarketing surveillance programs.
Immunization Schedules: Best Available Evidence for 2020
Review of the Advisory Committee Immunization Practices updates to the pediatric immunization schedule and significant revisions to the adult immunization schedule.
Vaccine Efficacy Required to Prevent or Extinguish COVID-19 Epidemic
Simulation experiments demonstrated that a vaccine efficacy of 80% is required to extinguish the ongoing COVID-19 pandemic without any other additional measures.
Phase 3 Trial of COVID-19 Vaccine Candidate mRNA-1273 Begins
The trial, which is the first to be implemented under Operation Warp Speed, is expected to enroll around 30,000 adults and will be conducted at multiple clinical research sites across the US.
Flu Vaccine Reduces Cardiovascular Mortality in Adults With Diabetes
The analysis included 241,551 patients monitored for a median of 4 years.
2008 to 2018 Saw Increase in Shingles Vaccination in Older Adults
From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years, with variations in vaccination rates.
FDA Fast-Tracks Two mRNA-Based COVID-19 Vaccine Candidates
The FDA has granted Fast Track designation to 2 of Pfizer and BioNTech’s vaccine candidates against COVID-19.
Model Estimates Herd Immunity Threshold for COVID-19
A mathematical model shows that SARS-CoV-2 disease-induced herd immunity level may be lower than the classical model assuming homogenous immunization.
Reactogenicity of Enhanced Influenza Vaccines in Older Adults
A team of investigators report on the findings from a randomized controlled trial of 3 enhanced influenza vaccines and a standard-dose vaccine in older adults.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Vaccine Information Center
